0 Σχόλια
0 Μοιράστηκε
110 Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
[ Latest Report ] Non-Oncology Precision Medicine Market Share, Growth by Business Developments 2025 to 2032Non-Oncology Precision Medicine Market Summary “The global Non-Oncology Precision Medicine Market is expected to reach to USD 57.3 billion by 2032, growing at a CAGR of 5.7% during 2025 to 2032” The TrendBridge Insights Research report, “Global Non-Oncology Precision Medicine Market Report 2025 – Future Opportunities, Latest Trends, In-depth Analysis, and Forecast...0 Σχόλια 0 Μοιράστηκε 166 Views 0 Προεπισκόπηση
-
Cancer/Tumor Profiling Market Size Projected to Reach USD 23.4 Billion by 2032“According to a new report published by Introspective Market Research, Cancer/Tumor Profiling Market by Technology, Cancer Type, and Application, The Global Cancer/Tumor Profiling Market Size Was Valued at USD 11.08 Billion in 2024 and is Projected to Reach USD 23.4 Billion by 2032, Growing at a CAGR of 9.8%.” Cancer/Tumor Profiling refers to the comprehensive molecular examination...0 Σχόλια 0 Μοιράστηκε 2χλμ. Views 0 Προεπισκόπηση
-
Rising Oncology Advances Boost Bladder Cancer Market ValuePrecision medicine is revolutionizing bladder cancer management strategies.Personalized treatment plans based on genetic profiling improve effectiveness.This trend is expanding opportunities within both therapeutics and diagnostics segments. The Bladder Cancer Therapeutics and Diagnostics Market is projected to register a robust CAGR of 10.2% from 2025 to 2031, with market size expanding...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
Sarcoma Drugs Market Forecast 2025–2031: Opportunities in Rare Cancer TherapiesThe rising demand for innovative cancer therapies is fueling the Sarcoma Drugs Market globally. Researchers are focusing on immunotherapy and combination therapies to improve treatment effectiveness. Such developments are strengthening the oncology drug pipeline. The Sarcoma Drugs Market is expected to register a CAGR of 7.9% from 2025 to 2031, with the market size expanding from US$ XX million...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση